Cargando…

Analysis of the Prognostic and Immunological Role of HSPB1 in Pituitary Adenoma: A Potential Target for Therapy

Background and Objectives: The diagnosis and treatment of pituitary adenomas with cavernous sinus invasion pose significant challenges for clinicians. The objective of this study is to investigate the expression profile and prognostic value of HSPB1 (heat shock protein beta-1) in pituitary adenomas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Sida, Li, Bin, Chen, Yiyuan, Li, Chuzhong, Zhang, Yazhuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220594/ https://www.ncbi.nlm.nih.gov/pubmed/37241117 http://dx.doi.org/10.3390/medicina59050885

Ejemplares similares

CCNB1 affects cavernous sinus invasion in pituitary adenomas through the epithelial–mesenchymal transition
por: Li, Bin, et al.
Publicado: (2019)

The clinical characteristics and molecular mechanism of pituitary adenoma associated with meningioma
por: Zhu, Haibo, et al.
Publicado: (2019)

Germline mutations in MEN1 are associated with the tumorigenesis of pituitary adenoma associated with meningioma
por: Zhu, Haibo, et al.
Publicado: (2020)

Risk factors and management associated with postoperative cerebrospinal fluid leak after endoscopic endonasal surgery for pituitary adenoma
por: Li, Bin, et al.
Publicado: (2022)

Smad3 and phospho-Smad3 are potential markers of invasive nonfunctioning pituitary adenomas
por: Liu, Chunhui, et al.
Publicado: (2016)

Research advances on the immune research and prospect of immunotherapy in pituitary adenomas
por: Nie, Ding, et al.
Publicado: (2021)

JAG1, Regulated by microRNA-424-3p, Involved in Tumorigenesis and Epithelial–Mesenchymal Transition of High Proliferative Potential-Pituitary Adenomas
por: Chen, Yiyuan, et al.
Publicado: (2020)

Metabolic profiling reveals distinct metabolic alterations in different subtypes of pituitary adenomas and confers therapeutic targets
por: Feng, Jie, et al.
Publicado: (2019)

Integration of Proteomics and Metabolomics Revealed Metabolite–Protein Networks in ACTH-Secreting Pituitary Adenoma
por: Feng, Jie, et al.
Publicado: (2018)

The Apoptosis Regulator 14-3-3η and Its Potential as a Therapeutic Target in Pituitary Oncocytoma
por: Zhao, Sida, et al.
Publicado: (2019)

Screening and Identification of Key Microenvironment-Related Genes in Non-functioning Pituitary Adenoma
por: Guo, Jing, et al.
Publicado: (2021)

Alterations of regional homogeneity and functional connectivity in pituitary adenoma patients with visual impairment
por: Song, Guidong, et al.
Publicado: (2017)

Identification of Differentially Expressed Genes in Pituitary Adenomas by Integrating Analysis of Microarray Data
por: Zhao, Peng, et al.
Publicado: (2015)

Corrigendum to “Identification of Differentially Expressed Genes in Pituitary Adenomas by Integrating Analysis of Microarray Data”
por: Zhao, Peng, et al.
Publicado: (2018)

LncRNA PCAT6 regulates the progression of pituitary adenomas by regulating the miR-139-3p/BRD4 axis
por: Zhao, Peng, et al.
Publicado: (2021)

Quantitative Ubiquitinomics Revealed Abnormal Ubiquitinated ATP7A Involved in Down-Regulation of ACTH in Silent Corticotroph Adenomas
por: Zhao, Sida, et al.
Publicado: (2022)

Identifying critical protein-coding genes and long non-coding RNAs in non-functioning pituitary adenoma recurrence
por: Guo, Jing, et al.
Publicado: (2021)

Predicting the regrowth of clinically non-functioning pituitary adenoma with a statistical model
por: Cheng, Sen, et al.
Publicado: (2019)

Analysis of Ki67, HMGA1, MDM2, and RB expression in nonfunctioning pituitary adenomas
por: Yao, Xiaohui, et al.
Publicado: (2017)

A Novel Three-LncRNA Signature Predicting Tumor Recurrence in Nonfunctioning Pituitary Adenomas
por: Cheng, Sen, et al.
Publicado: (2021)

Comparative Efficacy of AZD9496 and Fulvestrant on the Growth of Pituitary Adenoma via Blocking JAK2/STAT5B Pathway
por: Liu, Qian, et al.
Publicado: (2023)

Genomic and transcriptomic analysis of pituitary adenomas reveals the impacts of copy number variations on gene expression and clinical prognosis among prolactin-secreting subtype
por: Chen, Yiyuan, et al.
Publicado: (2020)

Immune Checkpoints: Therapeutic Targets for Pituitary Tumors
por: Nie, Ding, et al.
Publicado: (2021)

Phosphorylation of kinase insert domain receptor by cyclin-dependent kinase 5 at serine 229 is associated with invasive behavior and poor prognosis in prolactin pituitary adenomas
por: Xie, Weiyan, et al.
Publicado: (2016)

CDKN2A (p16(INK4A)) affects the anti-tumor effect of CDK inhibitor in somatotroph adenomas
por: Chen, Yiyuan, et al.
Publicado: (2021)

Identification of key genes in invasive clinically non-functioning pituitary adenoma by integrating analysis of DNA methylation and mRNA expression profiles
por: Cheng, Sen, et al.
Publicado: (2019)

Integrated analysis of DNA methylation and mRNA expression profiles to identify key genes involved in the regrowth of clinically non-functioning pituitary adenoma
por: Cheng, Sen, et al.
Publicado: (2020)

Long non-coding RNA C5orf66-AS1 is downregulated in pituitary null cell adenomas and is associated with their invasiveness
por: Yu, Guoqiang, et al.
Publicado: (2017)

In Vivo Characterization of Cortical and White Matter Microstructural Pathology in Growth Hormone-Secreting Pituitary Adenoma
por: Yuan, Taoyang, et al.
Publicado: (2021)

Immunohistochemical Study of NR2C2, BTG2, TBX19, and CDK2 Expression in 31 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas
por: Yao, Xiaohui, et al.
Publicado: (2019)

A two-circRNA signature predicts tumour recurrence in clinical non-functioning pituitary adenoma
por: Guo, Jing, et al.
Publicado: (2019)

The expression of TGF-β1, Smad3, phospho-Smad3 and Smad7 is correlated with the development and invasion of nonfunctioning pituitary adenomas
por: Zhenye, Li, et al.
Publicado: (2014)

Editorial: Targeted Therapy for Pituitary Adenomas
por: Araki, Takako, et al.
Publicado: (2019)

CDK5 and Its Activator P35 in Normal Pituitary and in Pituitary Adenomas: Relationship to VEGF Expression
por: Xie, Weiyan, et al.
Publicado: (2014)

Functional characterization of DLK1/MEG3 locus on chromosome 14q32.2 reveals the differentiation of pituitary neuroendocrine tumors
por: Chen, Yiyuan, et al.
Publicado: (2020)

The effect of endoscopic transsphenoidal somatotroph tumors resection on pituitary hormones: systematic review and meta-analysis
por: Nie, Ding, et al.
Publicado: (2023)

Whole-exome sequencing identifies variants in invasive pituitary adenomas
por: Lan, Xiaolei, et al.
Publicado: (2016)

Application of “mosiac sign” on T2-WI in predicting the consistency of pituitary neuroendocrine tumors
por: Nie, Ding, et al.
Publicado: (2022)

HspB1, HspB5 and HspB4 in Human Cancers: Potent Oncogenic Role of Some of Their Client Proteins
por: Arrigo, André-Patrick, et al.
Publicado: (2014)

Metabolic abnormalities in pituitary adenoma patients: a novel therapeutic target and prognostic factor
por: Zheng, Xin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_62bdoberd3jbv3gmrctkspj14v